Clinical Trial

CLABSI Prevention With Tissue Adhesive

Study acronym: Cya-No-CLABSI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2024 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-02-09; most recent amendment 2024-09-30.
Status change: Not Yet Recruiting → Recruiting 2023-04-04
Trial Details
NCT Number NCT05721677
Lead Sponsor Rabin Medical Center
Conditions Central-line Associated Blood Stream Infections (CLABSI)
Enrollment 600 participants
Start Date 2023-03-15
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2024-10-02